FDA clears Toshiba’s Adaptive Iterative Dose Reduction 3D technology

Toshiba America Medical Systems, Inc. announces the FDA clearance of Adaptive Iterative Dose Reduction 3D (AIDR 3D), the company's newest dose-reduction technology. Toshiba will offer the AIDR 3D software upgrade and related training, complimentary, to all existing Aquilion™ ONE, Aquilion Premium and Aquilion PRIME CT customers.

“Toshiba is constantly developing new technologies that help to improve imaging and patient care”

AIDR 3D is Toshiba's third generation iterative dose reconstruction software that incorporates significant system enhancements by reducing radiation dose compared to conventional scanning. It is a sophisticated algorithm designed to work in both the raw data and image data space, reducing noise while attempting to maintain image quality.

AIDR 3D can also be seamlessly integrated with ^SUREExposure^TM 3D, a software that calculates the minimum radiation exposure required for every exam. ^SUREExposure 3D adjusts the dose for each patient based on a pre-set, targeted level of image quality.

"Toshiba is constantly developing new technologies that help to improve imaging and patient care," said Tim Nicholson, senior manager, Market Development, CT Business Unit, Toshiba. "With the introduction of AIDR 3D, Toshiba is continuing its commitment to offering advanced dose reduction technologies."